The Medicines and Healthcare products Regulatory Agency (MHRA) approved marketing authorisation for Mounjaro, a new medicine, to control type 2 diabetes in adults. This authorization comes after promising results from clinical trials that showed Mounjaro effectively decreases blood sugar levels in patients. Mounjaro is a a once-weekly injection th